Biography

Dr Philip Kantoff grew up in New York City, attended Brown University College and Medical School, and did his internship/residency and chief residency in internal medicine at New York University Hospital/ Belleview Hospital in New York. He spent four years at the National Institutes of Health conducting research in gene therapy. He completed his medical oncology fellowship training at Dana-Farber Cancer Institute, Harvard Medical School, in 1987. Since then, he has been on the staff at the Dana-Farber Cancer Institute and Brigham &Womens Hospital. Dr Kantoff is currently the chief clinical research officer, director of The Lank Center for Genitourinary Oncology, and chief of the Division of Solid Tumor Oncology at the Dana-Farber Cancer Institute, Brigham & Womens Hospital. He is also the director of the Prostate Cancer Program and National Cancer Institute, sponsored SPORE in Prostate Cancer at the Dana-Farber Harvard Cancer Center. He is a professor of medicine at Harvard Medical School. Dr Kantoff has published over 200 research articles on a variety of topics, including the molecular basis of genitourinary cancers and improved treatments for patients afflicted with prostate cancer, kidney cancer, bladder cancer, and testicular cancer. His laboratory research involves understanding the genetics of prostate cancer. His clinical research involves clinical trials of novel therapeutic treatments for the genitourinary cancers. He teaches at Harvard Medical School, and lectures internationally to both medical and lay audiences.

Read More